Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$322,640,020
+$75,175,321 QoQ
Shares Held
1,493,289
+10.6% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#15
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $26,335,991,083 across 11 Drug Manufacturers - General names. BIIB ranks #10 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,145,229 | $6,171,342,532 | |
| 2 | JNJ |
Johnson & Johnson
|
19,286,904 | $4,898,295,007 | |
| 3 | AZN |
Astrazeneca PLC
|
25,750,245 | $4,882,761,455 | |
| 4 | ABBV |
AbbVie Inc.
|
11,548,053 | $2,905,952,055 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,873,343 | $2,425,224,575 | |
| 6 | AMGN |
Amgen Inc
|
3,816,942 | $1,382,191,036 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
10,421,131 | $1,316,605,688 | |
| 8 | PFE |
Pfizer Inc
|
43,233,122 | $1,041,053,576 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $322,640,020 | 1,493,289 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $247,464,699 | 1,349,832 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $256,874,475 | 1,459,597 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $223,203,331 | 1,593,399 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $181,705,620 | 1,446,816 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $175,843,094 | 1,285,027 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $188,092,668 | 1,230,007 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $242,678,568 | 1,251,953 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $294,441,999 | 1,270,132 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $281,983,662 | 1,307,720 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $342,895,090 | 1,325,096 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $344,156,436 | 1,339,078 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $390,108,056 | 1,369,521 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $377,716,821 | 1,358,547 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $382,332,089 | 1,380,659 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $381,676,233 | 1,429,499 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $296,930,521 | 1,455,970 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $303,340,026 | 1,440,361 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $325,830,553 | 1,358,080 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $397,939,405 | 1,406,196 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $479,823,568 | 1,385,692 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $334,565,893 | 1,195,946 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $301,293,862 | 1,230,474 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $361,745,330 | 1,275,188 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $350,606,348 | 1,310,433 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $398,791,609 | 1,260,483 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||